High Intensity Focused Ultrasound Therapy News This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

HIFU for Prostate Cancer an 'Experimental Therapy'HIFU for Prostate Cancer an 'Experimental Therapy'
Focal therapy for prostate cancer -- dubbed 'male lumpectomy' because it targets a lesion and not the whole prostate -- should undergo randomized trials first, argues Dr. Gerald Chodak. Medscape Urology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 11, 2014 Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news

EDAP outlines road to FDA approval for prostate cancer ultrasound therapy
French device maker EDAP TMS SA has a big month ahead as it pursues FDA approval for its Ablatherm-HIFU therapeutic ultrasound technology, preparing for regulatory inspections and launching a $9.3 million funding round. EDAP TMS SA, Food & Drug Administration (FDA)News Well, Regulatory/Clearance, Food & Drug Administration (FDA), Funding Roundup, Pre-Market Approval (PMA), Prostate, Ultrasoundread more (Source: Mass Device)
Source: Mass Device - May 29, 2014 Category: Medical Equipment Authors: Arezu Sarvestani Source Type: news

Press Release: EDAP's Ablatherm-HIFU FDA Panel Meeting Confirmed for July 30, 2014
EDAP TMS SANews Well, Press Release, Regulatory/Clearance, Food & Drug Administration (FDA), Pre-Market Approval (PMA), Prostate, Ultrasoundread more (Source: Mass Device)
Source: Mass Device - May 22, 2014 Category: Medical Equipment Authors: MassDevice Source Type: news

Prostate cancer: EDAP lands FDA date for therapeutic ultrasound
EDAP TMS lands a July date with FDA advisors to review therapeutic ultrasound in treatment of localized prostate cancer. France-based EDAP TMS SA will get its day with the FDA next month, when the agency's expert advisors will review EDAP's Ablatherm-HIFU therapeutic ultrasound technology for treatment of prostate cancer. EDAP TMS SA, Food & Drug Administration (FDA)News Well, Regulatory/Clearance, Food & Drug Administration (FDA), Pre-Market Approval (PMA), Prostate, Ultrasoundread more (Source: Mass Device)
Source: Mass Device - May 22, 2014 Category: Medical Equipment Authors: Arezu Sarvestani Source Type: news

EDAP Announces Reimbursement of HIFU Treatment for Prostate Cancer by France's Ministry of Health
Strong Recognition of EDAP's HIFU Technology by France's Health Authorities LYON, France, April 21, 2014 -- (Healthcare Sales & Marketing Network) -- EDAP TMS SA (EDAP), the global leader in therapeutic ultrasound, announced today the reimbursement of p... Devices, Oncology, ReimbursementEDAP TMS, High Intensity Focused Ultrasound, prostate cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 21, 2014 Category: Pharmaceuticals Source Type: news

EDAP Completes FDA Q&A Session for Its Ablatherm-HIFU Pre-Market Approval Application
(Source: Medical News (via PRIMEZONE))
Source: Medical News (via PRIMEZONE) - March 20, 2014 Category: Pharmaceuticals Source Type: news

Newer Uterine Fibroid Treatment Affords Less Efficacy, RiskNewer Uterine Fibroid Treatment Affords Less Efficacy, Risk
Magnetic-resonance-guided high-intensity focused ultrasound is a very good treatment option for a specific group of patients with uterine fibroids, say researchers. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 7, 2014 Category: Consumer Health News Tags: Radiology News Source Type: news

Hope for noninvasive treatment for breast cancer using MR-guided ultrasound
A technique that uses focused ultrasound under magnetic resonance (MR) guidance to heat and destroy tumors may offer a safe and effective treatment for breast cancer, according to research presented at the annual meeting of the Radiological Society of North America (RSNA).MR-guided focused ultrasound (MRgFUS) ablation is a noninvasive technique that requires no incision or puncture to perform. Instead, it uses the acoustic energy from high-intensity focused ultrasound to remove, or ablate, diseased tissue. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 5, 2013 Category: Consumer Health News Tags: Breast Cancer Source Type: news

SonaCare names CFO
High-intensity focused ultrasound developer SonaCare Medical has tapped Vincent (more) (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 6, 2013 Category: Radiology Source Type: news

NEJM: MRI-guided HIFU of brain targets tremors
High-intensity focused ultrasound (HIFU) delivered to the thalamus improved (more) (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 16, 2013 Category: Radiology Source Type: news

SonaCare highlights U.K. urology study
High-intensity focused ultrasound developer SonaCare Medical is highlighting (more) (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 31, 2013 Category: Radiology Source Type: news

Study features practical solution for MRI-ultrasound fusion to enable tumor-targeted, tissue-preserving prostate HIFU treatment
Study results published in the current issue of British Journal of Urology International (10.1111/bju.12223) demonstrate that new software to register and fuse information from magnetic resonance imaging (MRI) and ultrasound (US) images enables intraoperative visualization of tumors, not ordinarily seen in a US image. This technology has the potential to support new tissue-preserving treatments for prostate cancer, such as focal therapy... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 27, 2013 Category: Consumer Health News Tags: MRI / PET / Ultrasound Source Type: news

Magnetic resonance focused ultrasound fibroid treatment
is an alternative option for women who have fibroids. It can be an effective treatment for those who might otherwise have a hysterectomy, myomectomy or uterine artery embolisation. The procedure is non-invasive, requires no general anaesthetic or overnight hospitalisation which means patients may be able to return to work within a few days. The procedure is done in an MRI scanner, where high intensity focused ultrasound waves target the fibroids and heat the tissue until the fibroids are destroyed. The MRI provides real time thermal imaging to guide the treatment. The treatment typically last 1-3 hours and is done as an ...
Source: The Hysterectomy Association - July 4, 2013 Category: OBGYN Authors: Linda Parkinson-Hardman Tags: Alternatives to Hysterectomy Fibroids Source Type: news

Magnetic resonance focused ultrasound fibroid treatment
is an alternative option for women who have fibroids. It can be an effective treatment for those who might otherwise have a hysterectomy, myomectomy or uterine artery embolisation. The procedure is non-invasive, requires no general anaesthetic or overnight hospitalisation which means patients may be able to return to work within a few days. The procedure is done in an MRI scanner, where high intensity focused ultrasound waves target the fibroids and heat the tissue until the fibroids are destroyed. The MRI provides real time thermal imaging to guide the treatment. The treatment typically last 1-3 hours and is done as an ...
Source: The Hysterectomy Association - July 4, 2013 Category: OBGYN Authors: Linda Parkinson-Hardman Tags: Health fibroids magnetic resonance ultrasound Source Type: news